| Price and Chart delayed at least 15 mintues. |
|
Price
$ 9.86
|
Change
0.00
|
|
Open
0.00
|
% Change
0.0%
|
|
Prev Close
9.86
|
Volume
NA
|
|
Market Value
15 bil
|
P/E Ratio
NA
|
|
Bid
9.59
|
EPS
-1.60
|
|
Ask
0.00
|
Dividend
0.00
|
|
High
0.00
|
Yield
0.0
|
|
Low
0.00
|
Shares Out
1.51 bil
|
|
52wk High
14.20
|
52wk Low
5.41
|
|
Industry: Medical Instruments & Supplies
|
|
Sector: Healthcare
|
BSX Profile
A worldwide developer, manufacturer and marketer of medical devices, used in interventional cardiology, cardiac rhythm management, peripheral interventions, electrophysiology, neurovascular intervention, endoscopy, gynecology and neuromodulation.
Boston Scientific Corp.
One Boston Scientific Place
Natick, MA 01760-1537
Phone: (508) 650-8000
Fax: (508) 650-8923
Web Site: www.bostonscientific.com
BSX Wires Headlines
|
|
| 07.05.09 |
|
BUY OR SELL-Is new CEO reason to buy Boston Scientific?
|
|
| 07.02.09 |
|
Final Glance: Medical Devices companies
|
|
| 07.02.09 |
|
Midday Glance: Medical Devices companies
|
|
| 07.02.09 |
|
Early Glance: Medical Devices companies
|
|
| 07.01.09 |
|
Final Glance: Medical Devices companies
|
More BSX From Wires Headlines >
Forbes.com on BSX RSS
No news found in the past 30 days.BSX Press Releases
|
|
| 07.02.09 |
|
A.M. Best Downgrades Ratings of Argus Group Holdings Limited's Subsidiaries; Assigns Issuer... |
|
| 06.30.09 |
|
TBCToday.com Issues Hot Stocks In The Market Today: HD, NVDA, XLE, URE, BSX, F |
|
| 06.25.09 |
|
Boston Scientific Announces Retirement of Jim Tobin and Appointment of Ray Elliott as New... |
|
| 06.23.09 |
|
The following is an investment opinion release issued by Pennystockchaser.com |
|
| 06.23.09 |
|
MADIT-CRT Trial Meets Primary Endpoint |
More BSX Press Releases >
BSX Ratios & Returns
| Price-to-sales |
1.85 |
| Return on Equity |
0.0 |
| Operating Margin |
21.0 |
| Profit Margin |
-29.6% |
More BSX Ratios & Returns >
BSX Financials
| Sales |
$8.014 bil |
| Profits |
$-2.371 bil |
| Assets |
$26.105 bil |
| Employees |
24800.0 |
|
|
|
Boston Scientific is ranked # 792 on the 2009 Forbes 2000 List
|
|
Thomson / IBES Earnings Estimates on BSX
Accounting Risk
Buy/Hold/Sell Analysis
Forbes Investment Guru Commentary on BSX
RSS News Feed on BSX
|
A D V E R T I S E M E N T
|